A detailed history of City State Bank transactions in Novartis Ag stock. As of the latest transaction made, City State Bank holds 855 shares of NVS stock, worth $89,561. This represents 0.03% of its overall portfolio holdings.

Number of Shares
855
Previous 855 -0.0%
Holding current value
$89,561
Previous $98,000 15.31%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 22, 2022

SELL
$80.52 - $93.75 $2,818 - $3,281
-35 Reduced 3.93%
855 $72,000
Q4 2021

Mar 11, 2022

BUY
$79.7 - $88.13 $70,933 - $78,435
890 New
890 $75,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $225B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track City State Bank Portfolio

Follow City State Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.